The award recognized Titan Spine’s research paper “Implant Materials Generate Different Peri-Implant Inflammatory Factors: PEEK Promotes Fibrosis and Micro-Textured Titanium Promotes Osteogenic Factors.”
The paper was presented by Titan Spine CMO Paul Slosar, MD, of Spine Care Medical Group in San Francisco.
The study served to compare the company’s Endoskeleton Interbody Devices to devices made from PEEK.
More Articles on Devices:
MedTech Receive CE Mark for Robotic Spinal Surgery System
8 Trends in the Surgical Navigation Systems Market
Biomet, Medtronic, Misonix & More – 7 Key Notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
